Endogenous Agmatine Induced by Ischemic Preconditioning Regulates Ischemic Tolerance Following Cerebral Ischemia
Open Access
- 31 December 2017
- journal article
- research article
- Published by The Korean Society for Brain and Neural Science in Experimental Neurobiology
- Vol. 26 (6) , 380-389
Abstract
Kim JH, et al. Exp Neurobiol. 2017 Dec;26(6):380-389. https://doi.org/10.5607/en.2017.26.6.380Keywords
Funding Information
- Yonsei University College of Medicine (6-2014-0038)
- National Research Foundation of Korea (2017R1A2B2005350)
This publication has 50 references indexed in Scilit:
- Agmatine: clinical applications after 100 years in translationDrug Discovery Today, 2013
- Effects of agmatine on hypoxic microglia and activity of nitric oxide synthaseBrain Research, 2011
- Agmatine Attenuates Brain Edema through Reducing the Expression of Aquaporin-1 after Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- RETRACTED ARTICLE: Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell lineBMC Neuroscience, 2007
- Synthesis and Analgesic Activity Evaluation of Some Agmatine DerivativesMolecules, 2006
- Genomics of PreconditioningStroke, 2004
- Preconditioning‐Mediated NeuroprotectionAnnals of the New York Academy of Sciences, 2002
- INHIBITORY EFFECT OF AGMATINE ON NALOXONE-PRECIPITATED ABSTINENCE SYNDROME IN MORPHINE DEPENDENT RATSLife Sciences, 1997
- Agmatine treatment is neuroprotective in rodent brain injury modelsLife Sciences, 1995
- Induction of Ornithine Decarboxylase in Cerebral Cortex by Excitotoxin Lesion of Nucleus Basalis: Association with Postsynaptic Responsiveness and N‐Methyl‐d‐Aspartate Receptor ActivationJournal of Neurochemistry, 1990